查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088604

藥物傳輸裝置市場：按產品類型、治療領域、技術平台、應用和最終用戶分類的全球市場預測 – 2026-2032 年

Drug Delivery Devices Market by Product Type, Therapeutic Area, Technology Platform, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，藥物輸送設備市場將成長至 7.6754 億美元，複合年成長率為 8.40%。

主要市場統計數據
基準年 2025 4.363億美元
預計年份：2026年 470,890,000 美元
預測年份 2032 7.6754億美元
複合年成長率 (%) 8.40%

隨著慢性病、生物製藥和家庭醫療保健的興起，市場需求格局正在改變，藥物輸送裝置也從單純的產品功能演變為賦能醫療服務的平台。根據世界衛生組織統計，非傳染性疾病約佔全球死亡人數的74%，而國際糖尿病聯盟（IDF）估計，2021年全球有5.37億成年人患有糖尿病。這導致胰島素筆、自動注射器、輸液幫浦、吸入器、預填充式注射器和穿戴式注射器等產品的需求持續強勁。

這一成長主要得益於患者用藥便利性、劑量精準性、治療依從性以及注射和吸入療法在院外應用的增加。對製造商而言，競爭優勢越來越依賴人因工程、連網型設備功能、複合產品合規性、網路安全以及擴充性的全球生產能力。

藥物傳輸裝置領域的變革性變化

藥物輸送裝置的格局正朝著自我給藥、互聯醫療以及裝置與藥物的整合方向發展。生物製藥和特藥需要能夠保護其精細配方、實現劑量控制並減輕給藥負擔的給藥系統。同時，隨著以價值為導向的醫療保健模式的推進，人們越來越關注藥物依從性、臨床療效以及降低整體醫療成本等方面的證據。

人工智慧（AI）的累積影響

人工智慧 (AI) 正在對藥物輸送設備的整個價值鏈產生累積影響。 AI 可輔助進行初步設計模擬、故障模式分析、自動視覺檢測、預測性維護以及來自連網吸入器、幫浦、注射筆和穿戴式注射器的訊號檢測。這些應用由檢驗的數據管道管理，能夠降低品質差異並加速證據產生。

對關鍵區域的洞察

亞太地區正引領市場發展，這得益於其龐大的糖尿病和呼吸系統疾病患者群體、本地化生產能力，以及中國、印度、日本、韓國和澳洲等國生物製藥產品供應的不斷擴大。世界衛生組織指出，亞太地區國家是全球非傳染性疾病負擔的主要貢獻者，而日本、韓國和中國人口的老化也推動了對便捷型針筒、吸入器、預填充式注射器和家用輸液技術的需求成長。北美仍然是高價值的創新中心，這得益於美國食品藥物管理局（FDA）監管的複合製劑產品、先進的醫療保險報銷機制、完善的臨床試驗基礎設施，以及對智慧自動注射器、胰島素幫浦、智慧吸入器和穿戴式注射器的需求。

關鍵小組洞察

東協在製造業多元化、醫療科技產品組裝和糖尿病照護方面的重要性日益凸顯，新加坡、馬來西亞、泰國、越南、印尼和菲律賓等國為該地區的供應鏈網路和醫療保健現代化提供了支持。在海灣合作理事會（GCC）各國，鑑於全部區域糖尿病和肥胖症負擔沉重，專科診所、數位醫療和慢性病計畫正被列為優先事項，這催生了對優質注射器、連網用藥依從性支持工具和醫院到家庭配送模式的需求。

主要國家的概況

美國在互聯藥物傳輸創新、特殊生技藥品和FDA監管的複方製劑領域處於主導地位，這得益於自動注射器、胰島素幫浦、智慧吸入器和數位化用藥依從性解決方案的普及。在加拿大，需求受慢性病管理和遵守國際監管要求的影響，並著重於公共健保覆蓋、安全性和公平取得。墨西哥和巴西是拉丁美洲重要的成長市場，這得益於其糖尿病高發、私人醫療保健的擴張、公共部門的採購需求以及區域製造潛力。英國、德國、法國、義大利和西班牙憑藉其強大的醫藥生態系統、完善的臨床基礎設施、老齡化人口以及成熟的注射和吸入療法途徑，繼續在歐洲的推廣應用方面發揮核心作用。

為行業領導者提供的實用建議

產業領導者應優先考慮能夠適應多種配方、劑量、黏度和患者群體的模組化給藥裝置平台。為降低研發風險並加速產品推廣應用，必須在研發早期階段就納入人因工程檢驗、老年病患易用性、針頭安全特性、低操作力、劑量驗證以及簡化給藥流程等要素。

調查方法

本執行摘要基於公開認可的資訊來源的二手研究，包括世界衛生組織 (WHO)、國際糖尿病聯盟 (IDF)、美國食品藥物管理局 (FDA)、歐洲藥品管理局 (EMA)、國際標準化組織 (ISO)、國際電工委員會 (IEC)、經濟合作暨發展組織 (OECD)、世界銀行以及各國監管機構。分析內容涵蓋疾病負擔、醫療器材創新、監管標準、醫療服務趨勢、區域市場成熟度、慢性病管理、自我管理技術的應用。

結論

藥物輸送設備市場正邁入平台主導時代，其特徵是可實現自我給藥、互聯監測、生物製藥輸送以及人工智慧驅動的生命週期管理。推動市場需求的因素包括慢性病的普遍流行、人口老化、專科療法的拓展，以及在醫院、診所和居家照護環境中對便利、精準且擴充性的治療方案的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 藥物輸送裝置市場：依產品類型分類

  • 注射裝置
    • 注射器
    • 筆式注射器
      • 一次性筆式注射器
      • 可重複使用的筆式注射器
    • 自動噴油器
    • 無針注射器
  • 點滴裝置
    • 外置輸液泵
      • 胰島素幫浦
      • 攜帶式輸液泵
    • 植入式輸液泵
  • 吸入裝置
    • 定量噴霧吸入器
    • 乾粉吸入器
    • 噴霧器
      • 噴射霧化器
  • 經皮給藥裝置
  • 嵌入式裝置

第8章 藥物傳輸裝置市場：依治療領域分類

  • 代謝性疾病
  • 腫瘤學
    • 固體癌
    • 骨髓惡性腫瘤
  • 心血管疾病
    • 高血壓
    • 心臟衰竭
  • 呼吸系統疾病
  • 自體免疫疾病與發炎性疾病
  • 感染疾病
    • 病毒感染疾病
    • 細菌感染疾病
  • 神經病變
  • 疼痛管理
  • 內分泌疾病

第9章：藥物輸送設備市場：依技術平台分類

  • 機械輸送系統
  • 電子機械裝置
  • 生物可分解聚合物體系

第10章 藥物輸送裝置市場：依應用分類

  • 糖尿病
  • 腫瘤學
  • 心血管疾病
  • 疼痛管理

第11章 藥物傳輸設備市場：依最終用戶分類

  • 醫院
  • 診所
  • 門診手術中心
  • 居家醫療
  • 診斷中心

第12章 藥物輸送設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 藥物傳輸裝置市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 藥物輸送設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • AdminMed nanoBioSciences LLC
  • AptarGroup, Inc.
  • ARx, LLC
  • Bayer AG
  • BioSerenTach Inc.
  • CosMED Pharmaceutical Co., Ltd.
  • Credence MedSystems, Inc.
  • E3D Elcam Drug Delivery Devices
  • Innoture Medical Technology Limited
  • Kindeva Drug Delivery LP
  • Luye Pharma Group
  • Medtronic, Inc.
  • Midas Pharma GmbH
  • NanoPass Technologies Ltd.
  • Nitto Denko Corporation
  • Novartis AG
  • Owen Mumford Limited
  • Recipharm AB
  • Sparsha Pharma International Pvt. Ltd.
Product Code: MRR-B812DD5799B4

The Drug Delivery Devices Market is projected to grow by USD 767.54 million at a CAGR of 8.40% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 436.30 million
Estimated Year [2026] USD 470.89 million
Forecast Year [2032] USD 767.54 million
CAGR (%) 8.40%

Drug delivery devices are moving from product features to care-enabling platforms as chronic disease, biologics, and home-based treatment reshape demand. WHO reports that noncommunicable diseases account for about 74% of global deaths, while the International Diabetes Federation estimates 537 million adults were living with diabetes in 2021, creating sustained need for insulin pens, autoinjectors, infusion pumps, inhalers, prefilled syringes, and wearable injectors.

Growth is being driven by patient convenience, dose accuracy, therapy adherence, and the migration of injectable and inhaled therapies outside hospitals. For manufacturers, competitive edge increasingly depends on human factors engineering, connected device capabilities, combination-product compliance, cybersecurity, and scalable global manufacturing.

Transformative Shifts in the Drug Delivery Device Landscape

The drug delivery device landscape is shifting toward self-administration, connected care, and device-drug integration. Biologics and specialty medicines require delivery systems that protect sensitive formulations, enable controlled dosing, and reduce administration burden. At the same time, value-based healthcare is increasing the focus on adherence evidence, real-world outcomes, and reduced total cost of care.

Regulatory expectations are also transforming strategy. FDA combination-product oversight, EU Medical Device Regulation requirements, ISO 11608 standards for needle-based injection systems, and IEC 62304 software lifecycle controls are pushing companies to design safer, more traceable, and more digitally resilient devices.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force across the drug delivery device value chain. AI supports early design simulation, failure-mode analysis, automated visual inspection, predictive maintenance, and signal detection from connected inhalers, pumps, pens, and wearable injectors. These applications can reduce quality variation and accelerate evidence generation when governed by validated data pipelines.

The largest strategic impact will come from AI-enabled personalization, including adherence prediction, dose-support tools, and patient-risk stratification. However, adoption must align with FDA cybersecurity guidance, software as a medical device principles, data privacy rules, and auditable model governance to maintain trust and regulatory defensibility.

Key Regional Insights

Asia-Pacific is advancing on the strength of large diabetic and respiratory patient populations, local manufacturing capacity, and rising access to biologics in China, India, Japan, South Korea, and Australia. WHO identifies Asia-Pacific countries as major contributors to global noncommunicable disease burden, while aging demographics in Japan, South Korea, and China are increasing demand for easy-to-use injectors, inhalers, prefilled syringes, and home-based infusion technologies. North America remains a high-value innovation hub, supported by FDA-regulated combination products, advanced reimbursement pathways, strong clinical trial infrastructure, and demand for connected autoinjectors, insulin pumps, smart inhalers, and wearable injectors.

Europe benefits from established pharmaceutical manufacturing, EU MDR harmonization, strong pharmacovigilance systems, and sustainability expectations for device design, including growing pressure to reduce plastic waste and improve lifecycle management. Latin America is progressing through diabetes care modernization, expanding private-sector access, and broader use of injectable therapies in Mexico and Brazil. The Middle East is investing in specialty care infrastructure, digital health, and chronic disease management programs, particularly across high-income Gulf health systems. Africa remains earlier stage, with opportunities tied to essential medicines access, cold-chain reliability, donor-supported health programs, and affordable device formats suited to decentralized care delivery.

Key Group Insights

ASEAN is becoming more important for manufacturing diversification, medical technology assembly, and diabetes care access, with Singapore, Malaysia, Thailand, Vietnam, Indonesia, and the Philippines supporting regional supply networks and healthcare modernization. The GCC is prioritizing specialty clinics, digital health, and chronic disease programs amid high diabetes and obesity burdens reported across the region, creating demand for premium injectors, connected adherence tools, and hospital-to-home delivery models.

The European Union is shaping global compliance through MDR, sustainability policy, data protection standards, and coordinated health technology assessment priorities. BRICS countries offer scale through large patient pools, localization policies, and expanding domestic medtech capabilities, particularly in China, India, and Brazil. G7 markets lead in reimbursement sophistication, clinical adoption of biologics, regulatory science, and connected drug delivery innovation. NATO economies are increasingly emphasizing supply-chain resilience for critical medicines, polymers, electronics, needles, sensors, and device components as healthcare systems prioritize continuity of access.

Key Country Insights

The United States leads in connected drug delivery innovation, specialty biologics, and FDA-regulated combination products, supported by strong adoption of autoinjectors, insulin pumps, smart inhalers, and digital adherence solutions. Canada emphasizes public coverage, safety, and equitable access, with demand shaped by chronic disease management and alignment with international regulatory expectations. Mexico and Brazil are important Latin American growth markets due to diabetes prevalence, expanding private healthcare, public-sector procurement needs, and regional manufacturing potential. The United Kingdom, Germany, France, Italy, and Spain remain central to European adoption through strong pharmaceutical ecosystems, clinical infrastructure, aging populations, and established pathways for injectable and inhalation therapies.

Russia continues to prioritize local production and supply security, while China and India provide scale, cost competitiveness, expanding domestic device manufacturing, and rising demand for insulin delivery, respiratory drug delivery, and biologic administration systems. Japan and South Korea lead in precision engineering, aging-population needs, digital health readiness, and high-quality device manufacturing. Australia supports advanced care pathways, connected health uptake, chronic disease management programs, and regulatory alignment with international medical device standards, making it a strong reference market for safe, patient-centered drug delivery devices.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize modular drug delivery device platforms that can support multiple formulations, dose volumes, viscosities, and patient populations. Human factors validation, usability for elderly patients, needle-safety features, low-force activation, dose confirmation, and minimized administration steps should be embedded early to reduce development risk and improve adoption.

Companies should also invest in connected-device cybersecurity, AI governance, sustainable materials, supplier redundancy, and localized regulatory strategies. Partnerships with pharmaceutical developers, contract manufacturers, digital health specialists, healthcare providers, and patient-support programs can accelerate evidence generation, improve adherence, strengthen market access, and support lifecycle differentiation without compromising safety or compliance.

Research Methodology

This executive summary is grounded in secondary research from recognized public sources, including WHO, International Diabetes Federation, FDA, EMA, ISO, IEC, OECD, World Bank, and national regulatory agencies. Insights were structured around disease burden, device innovation, regulatory standards, healthcare delivery trends, regional market maturity, chronic disease management, and the adoption of self-administration technologies.

The analysis applies triangulation across regulatory publications, clinical-care trends, demographic datasets, reimbursement signals, public health indicators, and supply-chain evidence. Emphasis was placed on verified directional evidence rather than unsupported market-size, market-share, or forecast claims, ensuring that conclusions remain credible for strategic planning and industry intelligence.

Conclusion

The drug delivery devices market is entering a platform-driven era defined by self-administration, connected monitoring, biologics delivery, and AI-supported lifecycle management. Demand is supported by chronic disease prevalence, aging populations, expanding specialty therapeutics, and the need for convenient, accurate, and scalable treatment delivery across hospital, clinic, and home-care settings.

Winning organizations will combine regulatory discipline with patient-centered design, resilient manufacturing, digital security, sustainable engineering, and region-specific commercialization. As healthcare systems shift care closer to the patient, drug delivery devices will remain central to improving adherence, outcomes, treatment continuity, and access.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Drug Delivery Devices Market, by Product Type

  • 7.1. Injection Devices
    • 7.1.1. Syringes
    • 7.1.2. Pen Injectors
      • 7.1.2.1. Disposable Pen Injectors
      • 7.1.2.2. Reusable Pen Injectors
    • 7.1.3. Autoinjectors
    • 7.1.4. Needle-Free Injectors
  • 7.2. Infusion Devices
    • 7.2.1. External Infusion Pumps
      • 7.2.1.1. Insulin Pumps
      • 7.2.1.2. Ambulatory Infusion Pumps
    • 7.2.2. Implantable Infusion Pumps
  • 7.3. Inhalation Devices
    • 7.3.1. Metered Dose Inhalers
    • 7.3.2. Dry Powder Inhalers
    • 7.3.3. Nebulizers
      • 7.3.3.1. Jet Nebulizers
  • 7.4. Transdermal Delivery Devices
  • 7.5. Implantable Devices

8. Drug Delivery Devices Market, by Therapeutic Area

  • 8.1. Metabolic Disorders
  • 8.2. Oncology
    • 8.2.1. Solid Tumors
    • 8.2.2. Hematologic Malignancies
  • 8.3. Cardiovascular Diseases
    • 8.3.1. Hypertension
    • 8.3.2. Heart Failure
  • 8.4. Respiratory Diseases
  • 8.5. Autoimmune And Inflammatory Diseases
  • 8.6. Infectious Diseases
    • 8.6.1. Viral Infections
    • 8.6.2. Bacterial Infections
  • 8.7. Neurological Disorders
  • 8.8. Pain Management
  • 8.9. Hormonal Disorders

9. Drug Delivery Devices Market, by Technology Platform

  • 9.1. Mechanical Delivery Systems
  • 9.2. Electromechanical Devices
  • 9.3. Biodegradable Polymer Systems

10. Drug Delivery Devices Market, by Application

  • 10.1. Diabetes
  • 10.2. Oncology
  • 10.3. Cardiovascular diseases
  • 10.4. Pain management

11. Drug Delivery Devices Market, by End User

  • 11.1. Hospitals
  • 11.2. Clinics
  • 11.3. Ambulatory Surgical Centers
  • 11.4. Home Care Settings
  • 11.5. Diagnostic Centers

12. Drug Delivery Devices Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Drug Delivery Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Drug Delivery Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. AdminMed nanoBioSciences LLC
  • 16.2. AptarGroup, Inc.
  • 16.3. ARx, LLC
  • 16.4. Bayer AG
  • 16.5. BioSerenTach Inc.
  • 16.6. CosMED Pharmaceutical Co., Ltd.
  • 16.7. Credence MedSystems, Inc.
  • 16.8. E3D Elcam Drug Delivery Devices
  • 16.9. Innoture Medical Technology Limited
  • 16.10. Kindeva Drug Delivery L.P.
  • 16.11. Luye Pharma Group
  • 16.12. Medtronic, Inc.
  • 16.13. Midas Pharma GmbH
  • 16.14. NanoPass Technologies Ltd.
  • 16.15. Nitto Denko Corporation
  • 16.16. Novartis AG
  • 16.17. Owen Mumford Limited
  • 16.18. Recipharm AB
  • 16.19. Sparsha Pharma International Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DRUG DELIVERY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL DRUG DELIVERY DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL DRUG DELIVERY DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL DRUG DELIVERY DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INJECTION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INJECTION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SYRINGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SYRINGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PEN INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PEN INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PEN INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DISPOSABLE PEN INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DISPOSABLE PEN INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DISPOSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL REUSABLE PEN INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL REUSABLE PEN INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL REUSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AUTOINJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AUTOINJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AUTOINJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEEDLE-FREE INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INFUSION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INFUSION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXTERNAL INFUSION PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL EXTERNAL INFUSION PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXTERNAL INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INSULIN PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INSULIN PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AMBULATORY INFUSION PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AMBULATORY INFUSION PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AMBULATORY INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL IMPLANTABLE INFUSION PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL IMPLANTABLE INFUSION PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL IMPLANTABLE INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INHALATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INHALATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INHALATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL METERED DOSE INHALERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL METERED DOSE INHALERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL METERED DOSE INHALERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DRY POWDER INHALERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DRY POWDER INHALERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DRY POWDER INHALERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEBULIZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEBULIZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL JET NEBULIZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL JET NEBULIZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL JET NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TRANSDERMAL DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TRANSDERMAL DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TRANSDERMAL DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SOLID TUMORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SOLID TUMORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SOLID TUMORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HYPERTENSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HYPERTENSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HYPERTENSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEART FAILURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HEART FAILURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEART FAILURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL RESPIRATORY DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AUTOIMMUNE AND INFLAMMATORY DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AUTOIMMUNE AND INFLAMMATORY DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL AUTOIMMUNE AND INFLAMMATORY DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HORMONAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HORMONAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HORMONAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MECHANICAL DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MECHANICAL DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MECHANICAL DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ELECTROMECHANICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ELECTROMECHANICAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ELECTROMECHANICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIODEGRADABLE POLYMER SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BIODEGRADABLE POLYMER SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIODEGRADABLE POLYMER SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL DIABETES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. GCC DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 255. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 256. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 257. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 258. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 259. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 260. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 261. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 262. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
  • TABLE 263. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 264. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 265. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. GCC DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. G7 DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 298. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 300. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 301. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 302. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 303. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 304. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 305. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 306. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
  • TABLE 308. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 309. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 310. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 311. G7 DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 312. NATO DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 315. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 316. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 317. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 318. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 319. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 320. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 321. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 322. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
  • TABLE 323. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 324. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 325. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 326. NATO DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 327. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
  • TABLE 341. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 342. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 343. CANADA DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 344. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 345. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 346. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 347. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 348. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 349. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 350. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 351. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 352. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 353. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2032 (USD MILLION)
  • TABLE 354. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)

TABL